Key result
Combined lutein and lycopene reduces carotid intima-media thickness by ~0.07 mm in subclinical atherosclerosis.
Why the study?
Does lutein and lycopene supplementation reduce carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis?
RCT (n=144)
Double-blind
Randomly assigned
No
Does lutein and lycopene supplementation reduce carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis?
Lutein and lycopene supplementation significantly decreased carotid intima-media thickness in subjects with subclinical atherosclerosis, with the combination showing greater efficacy than lutein alone.
Answers are grounded in this paper and cite their sources.
Lutein ± lycopene reduced CAIMT over 12 months; extends carotenoid data on surrogate markers but requires outcome trials before practice change.
The aim of the present study was to evaluate the effects of lutein and lycopene supplementation on carotid artery intima-media thickness (CAIMT) in subjects with subclinical atherosclerosis. A total of 144 subjects aged 45-68 years were recruited from local communities. All the subjects were randomly assigned to receive 20 mg lutein/d (n 48), 20 mg lutein/d+20 mg lycopene/d (n 48) or placebo (n 48) for 12 months. CAIMT was measured using Doppler ultrasonography at baseline and after 12 months, and serum lutein and lycopene concentrations were determined using HPLC. Serum lutein concentrations increased significantly from 0·34 to 1·96 μmol/l in the lutein group (P< 0·001) and from 0·35 to 1·66 μmol/l in the combination group (P< 0·001). Similarly, serum lycopene concentrations increased significantly from 0·18 to 0·71 μmol/l in the combination group at month 12 (P< 0·001), whereas no significant change was observed in the placebo group. The mean values of CAIMT decreased significantly by 0·035 mm (P= 0·042) and 0·073 mm (P< 0·001) in the lutein and combination groups at month 12, respectively. The change in CAIMT was inversely associated with the increase in serum lutein concentrations (P< 0·05) in both the active treatment groups and with that in serum lycopene concentrations (β = - 0·342, P= 0·031) in the combination group. Lutein and lycopene supplementation significantly increased the serum concentrations of lutein and lycopene with a decrease in CAIMT being associated with both concentrations. In addition, the combination of lutein and lycopene supplementation was more effective than lutein alone for protection against the development of CAIMT in Chinese subjects with subclinical atherosclerosis, and further studies are needed to confirm whether synergistic effects of lutein and lycopene exist.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2013) conducted an RCT in Subclinical atherosclerosis (n=144). Lutein and lycopene vs. Placebo was evaluated on Change in carotid artery intima-media thickness (CAIMT) at 12 months (p=<0.001). Supplementation with a combination of /d lutein and /d lycopene for 12 months decreased carotid artery intima-media thickness by 0.073 mm in subjects with subclinical atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: